FOVAX Fees and Costs — First Trust/Confluence Small Cap Value Fund, Class A
Data updated: 2026-03-25
The net expense ratio is 1.60%: a 1.00% management fee, a 0.25% 12b-1 fee plus 2.30% other expenses, less a 1.95% fee waiver. This share class carries a maximum front-end sales load of 5.50%. In fiscal 2025 the fund paid $20K in broker commissions, 0.1140% of average net assets, and portfolio turnover was 17%.
FOVAX Fees and Expenses
Annual operating expenses and sales charges of FOVAX. Prospectus, as of February 28, 2025.
| Annual operating expenses | |
|---|---|
| Management fee | 1.00% |
| 12b-1 fee | 0.25% |
| Other expenses | 2.30% |
| Gross expense ratio | 3.55% |
| Fee waiver | −1.95% |
| Net expense ratio | 1.60% |
| Sales charges | |
|---|---|
| Max front load | 5.50% |
| Max deferred load | 0.00% |
| Redemption fee | — |
| Expense limitation in place (N-CEN) | Yes |
| Fees waived or reduced during the year | Yes |
| Waived fees subject to recoupment | Yes |
FOVAX Costs Over Time
On $10,000 invested in FOVAX, assuming 5% a year before costs, total costs come to $1,701 over 5 years, cutting the return by 2.96% a year. Illustration, not a forecast: it assumes today's net expense ratio throughout (a fee waiver may end).
| $10,000 invested | Sell after 1 year | Sell after 3 years | Sell after 5 years |
|---|---|---|---|
| Value before costs | $10,500 | $11,576 | $12,763 |
| Sales charges | $550 | $550 | $550 |
| Fund expenses (net expense ratio 1.60%) | $159 | $492 | $846 |
| Trading costs (broker commissions) | $11 | $35 | $60 |
| Lost growth on money paid in costs | $27 | $113 | $244 |
| Total costs | $748 | $1,190 | $1,701 |
| Value after costs | $9,752 | $10,387 | $11,062 |
| Impact on return, per year | 7.48% | 3.73% | 2.96% |
FOVAX Trading Costs
Brokerage costs reported on SEC Form N-CEN for the fiscal year ending October 31, 2025.
- Explicit cost rate (commissions ÷ average net assets): 0.1140%
- Total broker commissions: $20K
- Bought from dealers (principal trades, not a cost): —
- Portfolio turnover (prospectus): 17%
- Securities lending: none during the year
FOVAX Agency Brokers
Commissions paid.
| Broker | Amount | Share |
|---|---|---|
| JP MORGAN SECURITIES LLC | $8K | 38.11% |
| Stifel, Nicolaus & Company, Incorporated | $7K | 32.32% |
| Raymond James & Associates, Inc. | $6K | 29.57% |
First Trust/Confluence Small Cap Value Fund Share Classes
Net expense ratio and maximum front-end load of each share class, cheapest first.
| Ticker | Class | Net expense ratio | Front load |
|---|---|---|---|
| FOVIX | Class I | 1.35% | none |
| FOVAX | Class A | 1.60% | 5.50% |
| FOVCX | Class C | 2.35% | none |
For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.